Tag:
OptiNose
Latest Headlines
Latest Headlines
OptiNose testing nose-to-brain delivery tech with migraine drug
OptiNose is launching a Phase III trial to test the migraine drug sumatriptan with its intranasal nose-to-brain drug delivery technology. The technology is designed to improve on current nasal
Nose-to-brain delivery has a rat problem
Nick Taylor at in-PharmaTechnologist.com filed an interesting report on nose-to-brain drug delivery from the American Association of Pharmaceutical Scientists' annual meeting in New Orleans. The nose
OptiNose aims high with nasal drug delivery device
Yardley-PA based OptiNose is hoping to use its nasal-spray device to revolutionize the way existing drugs are delivered, boosting efficacy, lowering dosages and potentially replacing vaccines all
OptiNose has nose for news, investors
The Philadelphia Inquirer ran a feature this week on Yardley, Pa.-based drug-delivery company OptiNose. The paper profiles Peter Miller and Ramy Mahmoud, both of whom jumped from their respective
OptiNose plans move to U.S. after gaining $48M
OptiNose took a nontraditional approach to financing a slate of late-stage trials of its intranasal drug delivery technology. Rather than put together a new syndicate of venture groups to chip in on
OptiNose plans move to US after gaining $48M for PhIII trials
OptiNose ASA took a nontraditional approach to financing a slate of late-stage trials of its intranasal drug delivery technology. Rather than put together a new syndicate of venture groups to chip in
